Home › Funds › KVP Capital Advisors, LP › ACHV
KVP Capital Advisors, LP position in ACHV
ACHIEVE LIFE SCIENCE INC · Health Care
KVP Capital Advisors, LP reported holding 462,355 shares of ACHV (ACHIEVE LIFE SCIENCE INC) in its Q2 2026 13F filing — a position valued at US$3.0M, representing 2.22% of its reported portfolio and ranking #15 among its reported holdings. KVP Capital Advisors, LP has disclosed ACHV holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How KVP Capital Advisors, LP's ACHV position evolved
KVP Capital Advisors, LP first disclosed a stake in ACHV in Q4 2025 at 462,355 shares (US$2.3M). The position peaked in Q2 2026 at 462,355 shares, worth US$3.0M. Across 3 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 462,355 shares valued at US$3.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 462.36K | $2.30M | New |
| Q1 2026 | 462.36K | $1.36M | Hold |
| Q2 2026 | 462.36K | $3.02M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ACHV and 13F data
ACHV (ACHIEVE LIFE SCIENCE INC) is a Health Care company. 63 other funds we track also report a position in ACHV — the largest reported positions include Frazier Life Sciences Management, L.P. (US$49.7M), TPG GP A, LLC (US$44.9M), venBio Partners LLC (US$38.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACHV
- Frazier Life Sciences Management, L.P. 7.61M sh · $49.72M · Q2 2026
- TPG GP A, LLC 6.88M sh · $44.91M · Q2 2026
- venBio Partners LLC 5.91M sh · $38.62M · Q2 2026
- Logos Global Management LP 5.42M sh · $35.43M · Q2 2026
- Paradigm Biocapital Advisors LP 4.95M sh · $32.34M · Q2 2026
- Propel Bio Management, LLC 4.03M sh · $26.34M · Q2 2026
- Venrock Adviser, LLC 2.75M sh · $17.96M · Q2 2026
- Vivo Capital, LLC 2.75M sh · $17.96M · Q2 2026
- Simplify Asset Management Inc. 1.43M sh · $9.35M · Q2 2026
- Spruce Street Capital LP 736.64K sh · $4.81M · Q2 2026
More on KVP Capital Advisors, LP
FAQ
How long has KVP Capital Advisors, LP held ACHV?
KVP Capital Advisors, LP has disclosed ACHV holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is KVP Capital Advisors, LP's current position in ACHV?
As of Q2 2026, KVP Capital Advisors, LP holds 462.36K shares of ACHV (ACHIEVE LIFE SCIENCE INC), valued at $3.02M, representing 2.22% of its reported portfolio and ranking #15.
Has KVP Capital Advisors, LP been buying or selling ACHV?
In the latest 13F filing (Q2 2026), KVP Capital Advisors, LP held unchanged its position in ACHV. The position peaked in Q2 2026 at 462.36K shares.
Which other funds hold ACHV?
Other major institutional holders of ACHV include Frazier Life Sciences Management, L.P., TPG GP A, LLC, venBio Partners LLC, among 63 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.